Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease

Annals of Neurology

Volumn 43, Issue 3, 1998, Pages 303-310

  Jack Jr , Clifford R ^a   Petersen, Ronald C ^a   Xu, Yue Cheng ^a   O'Brien, Peter C ^a   Waring, Stephen C ^a   Tangalos, Eric G ^a   Smith, Glenn E ^a   Ivnik, Robert J ^a   Thibodeau, Stephen N ^a   Kokmen, Emre ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SCINTISCANNING; DISEASE ASSOCIATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATROPHY; GENOTYPE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 2642673613     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430307     Document Type: Article

References (67)

1. Corder EH, Saunders AM, Strittmatter WJ. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923
2. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high acidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981
3. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet 1994;7:180-184
4. Kuussisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 1994;309:636-638
5. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein E4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754
6. Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994;54: 643-649
7. Roses AD. A model for susceptibility polymorphisms for complex disease: apolipoprotein E and Alzheimer disease. Neurogenetics 1997;1:3-11
8. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals. JAMA 1995;273:1274-1278
9. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: The NIMH Genetics Initiative. Neurology 1997;48:139-147
10. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171
11. Zhou Z, Smith JD, Greengard P, et al. Alzheimer amyloid-Beta peptide forms denaturant-resistant complex with type ∈3 but not type ∈4 isoform of native apolipoprotein E. Mol Med 1996;2:175-180
12. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid beta-peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102
13. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-530
14. Poirier J, Delisle M-C, Quirion R, et al. Apolipoprotein ∈4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995;92:12260-12264
15. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170
16. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1104
17. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242
18. Terry RD, Peck A, DeTeresa R, et al. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981;10:184-192
19. Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebr Cortex 1991;1:103-116
20. Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology 1981;5:549-564
21. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259
22. Hyman BT, Gomez-Isla T. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 1994;15:353-354
23. Hooper MW, Vogel FS. The limbic system in Alzheimer's disease: a neuropathologic investigation. Am J Pathol 1976;85: 1-19
24. Convit A, de Leon MJ, Golomb J, et al. Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q 1993;64:371-387
25. Convit A, de Leon MH, Tarshish C, et al. Hippocampal volume losses in minimally impaired elderly. Lancet 1995;345:266
26. Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188
27. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54
28. Killiany RJ, Moss MB, Albert MS, et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-954
29. Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm 1995;9:73-86
30. Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR 1994;15:927-937
31. Soininen HS, Partanen K, Pitkanen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44:1660-1668
32. Pearlson G, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992;49: 402-408
33. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E ∈4 in Alzheimer's disease. Ann Neurol 1996;39:62-70
34. Growdon J, Locasio J, Corkin S, et al. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;46:A419 (Abstract)
35. Waring S, Rocca W, Smith G, et al. Apolipoprotein E and rate of clinical progression in Alzheimer's disease. Neurology 1996; 46:A348 (Abstract)
36. de Leon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 1997;18:1-11
37. Petersen RC, Kokmen E, Tangalos EG, et al. Mayo Clinic Alzheimer's Disease Patient Registry. Aging 1990;2:408-415
38. Petersen RC, Smith G, Kokmen E, et al. Memory function in normal aging. Neurology 1992;42:396-401
39. Petersen RC, Smith GE, Ivnik RJ, et al. Memory function in very early Alzheimer's disease. Neurology 1994;44:867-872
40. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944
41. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414
42. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794
43. Jack CR Jr, Bentley M, Twomey CK, Zinsmeister AR. MR-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology 1990;176: 205-209
44. Jack CR Jr. MRI-based hippocampal volume measurements in epilepsy. Epilepsia 1994;35(suppl 6):S21-S29
45. Jack CR Jr, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of hippocampal formation. Radiology 1990;175:423-429
46. Jack CR Jr, Twomey CK, Zinsmeister AR, et al. Anterior temporal lobes and hippocampal formations: normative volumetric measurements with MR images in young adults. Radiology 1989;172:549-554
47. Duvernoy HM. The human hippocampus. An atlas of applied anatomy. Munich: JF Bergmann, 1988:77-91
48. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-1750
49. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995;45:17-23
50. Mattis S. Mental status examination for organic mental syndromes in the elderly patient. In: Bellak KT, ed. Geriatric psychiatry. New York: Grune and Stratton, 1976
51. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
52. Plassman BL, Welsh-Bohmer KA, Bigler ED, et al. Apolipoprotein E4 allele and hippocampal volume in twins with normal cognition. Neurology 1997;48:985-989
53. Arriagada PV, Growdow JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but no senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639
54. Feskens EJM, Havekes LM, Kalmijn S, et al. Apolipoprotein ∈4 allele and cognitive decline in elderly men. BMJ 1994;309: 1202-1206
55. Henderson A, Easteal S, Jorm A, et al. Apolipoprotein E allele 4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-1390
56. Yamaguchi S, Nakagawa T, Arai H, et al. Temporal progression of hippocampal atrophy and apolipoprotein E gene in Alzheimer's disease. J Am Geriatr Soc 1996;44:216-217
57. Lehtovirta M, Soininen H, Laakso MP, et al. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E ∈4 allele. J Neurol Neurosurg Psychiatry 1996;60:644-649
58. Lehtovirta M, Laakso MP, Soininen H, et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer's patients with different apolipoprotein E genotypes. Neuroscience 1995; 67:65-72
59. Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E ∈4 and incidence of Alzheimer disease in a community population of older persons. JAMA 1997;277:822-824
60. Rebeck GW, Reiter JS, Strickland DK, et al. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580
61. de Leon MJ, Golomb J, George AE, et al. The radiologie prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR 1993;14:897-906
62. Kaye JA, Swihart T, Howieson D, Dame A. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997;48:1297-1304
63. Kakulas BA, Wilton SD, Fabian VA, et al. Apolipoprotein-E genotyping in the diagnosis of Alzheimer's disease in autopsy confirmed series. Lancet 1996;348:483 (Letter)
64. Relkin NR, Tanzi R, Breitner J, et al. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996;347:1091-1095
65. Roses AD. Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease. J Am Gerontol Soc 1996;44:1-3
66. Saunders AM, Hulette C, Welsch KA, et al. Specificity, sensitivity and predictive value of apolipoprotein E genotyping for sporadic Alzheimer disease. Lancet 1996;348:90-93
67. Hyman BT. Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease. J Am Gerontol Soc 1996;44:1469-1471